The clinical value of individualization of transrectal ultrasound guided prostate biopsy strategies for prostate cancer detection
10.3760/cma.j.issn.1673-4904.2012.32.005
- VernacularTitle:经直肠超声引导个体化穿刺活检在前列腺癌诊断中的临床价值
- Author:
Minli LU
;
An WU
;
Yingying WANG
- Publication Type:Journal Article
- Keywords:
Prostatic neoplasms;
Biopsy,needle;
Ultrasonography
- From:
Chinese Journal of Postgraduates of Medicine
2012;(32):13-15
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical value of individualization of transrectal ultrasound guided prostate biopsy strategies for prostate cancer detection.Methods Ninety-seven patients who were considered having prostate cancer underwent individualization prostate biopsy strategies as individualization group.Fifty-two patients who were considered having prostate cancer underwent systemic 6-core prostate biopsy as control group.The detection rate of prostate cancer and rate of complications were compared between two groups.Results The detection rate of prostate cancer in individualization group was 43.3 ％(42/97),there was no significant difference in age and prostate volume between the prostate cancer patients and the non-prostate cancer patients(P＞0.05),but the prostate specific antigen(PSA)level of the prostate cancer patients was significantly higher than that of the non-prostate cancer patients[(26.4±2.9)μ g/L vs.(11.2±3.1)μ g/L,P=0.0000].The detection rate of prostate cancer in control group was 23.1％(12/52),the detection rate of prostate cancer in individualization group was significantly higher than that in control group(P=0.014).There was no significant difference in the rate of complications between two groups(P＞0.05).Conclusions The first detection rate of prostate cancer in individualization of transrectal ultrasound guided prostate biopsy strategies is higher than that by systemic 6-core prostate biopsy,and the rate of complications is not increased.The individualization of transrectal ultrasound guided prostate biopsy strategies for prostate cancer is good,safety,deserve clinical expansion.
